The bioengineering of exogenic organs and/or cells for use in regenerative medicine

Rajagopal N. Aravalli, Maple Shiao, Wei Cheng Lu, Hui Xie, Clairice Pearce, Nikolas G. Toman, Georgette Danczyk, Christopher Sipe, Zachary D. Miller, Andrew Crane, Joseph Voth, Walter C. Low, Clifford J. Steer

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

The potential for developing gene therapy technologies is evident from the recent surge in research activity. The use of these emerging technologies, along with blastocyst complementation, could greatly enhance our ability to produce exogenic organs and cells in a relatively short period of time. Furthermore, the generation of human-animal organ chimeras, together with their associated vasculature, could be developed to overcome the global problem of organ shortage for transplantation, as well as complications associated with immune rejection. It will be imperative that we understand the underlying conditions for stem cell growth in a developmental environment, to determine if cross-species chimeras can be therapeutically developed. Importantly, the combination of gene editing and blastocyst complementation has created an entirely new and exciting field of medicine, one that we envision will have a critical role for precision medicine.

Original languageEnglish (US)
Title of host publicationEngineering in Medicine
Subtitle of host publicationAdvances and Challenges
PublisherElsevier
Pages381-415
Number of pages35
ISBN (Electronic)9780128130681
ISBN (Print)9780128135143
DOIs
StatePublished - Jan 1 2018

Keywords

  • Blastocyst complementation
  • Cell transplantation
  • Exogenic cells
  • Exogenic organs
  • Gene editing
  • Precision medicine
  • Transplantation
  • Xenotransplantation

Fingerprint Dive into the research topics of 'The bioengineering of exogenic organs and/or cells for use in regenerative medicine'. Together they form a unique fingerprint.

Cite this